Johnson, Marcou, Isaacs & Nix, LLC

03/03/2025

JMIN’s John Sears and Carin Miller will each moderate panel discussions at , AUTM’s annual conference at the Ga***rd National Resort and Convention Center this week.

On March 4th, Carin and other speakers will explore ways to prepare university animal and ag tech innovations and early-stage companies for investment success in their program - "Bringing Home the Bacon: Investment Challenges and Opportunities in Animal and Ag Tec.”

John’s March 5th presentation - 'Wonders in Venture Land: An Inside Look from Investors Focused on Early-Stage University Spin-outs” - focuses on new venture creation and the creative ways VC firms can partner and work with universities.

12/14/2024

JMIN's Erin Daly discusses how the interpretation of specific chemical terms in Alnylam's patents could have significant implications for the biotech industry and patent drafting practices.

The clash between these two companies spotlights a fascinating intersection of chemical innovation and patent law and serves as a reminder for the biotech and pharmaceutical industries that even the smallest details can have outsized consequences.

09/24/2024

JMIN’s Dr. Christopher D. Southgate analyzes federal cases, PTAB decisions, and proposed legislation impacting eligibility for patents aimed at detecting genetic mutations or gene expression profiles.

Over the past 10-15 years, U.S. Supreme Court rulings have profoundly affected the eligibility of patents with claims drawn to biomarker/gene mutation diagnostic assays. Read more.

09/19/2024

JMIN congratulates Dr. Rachel Dorin, co-founder and CEO of our valued client Terapore Technologies, Inc., on receiving the Bayh-Dole Coalition's American Innovator Award. Dr. Dorin (pictured here with JMIN senior partner John Sears) and four other honorees are featured in the coalition’s second annual Faces of American Innovation Report and formally received awards at a September 19th ceremony in Washington, D.C.

09/17/2024

John S. Sears explains , why it matters, and strategies companies can leverage to maximize PTA and the value of their .

A single day of additional patent protection can mean millions of dollars in revenue. This is where effective strategies to maximize Patent Term Adjustment become crucial.

09/14/2024

With the validity of in a state of flux, John S. Sears discusses what should do to protect , prevent talent loss to competitors, and secure investor confidence.

With the legal landscape in flux after a federal court's blockage of the FTC's noncompete ban, startups should reconsider strategies for safeguarding sensitive information.

08/22/2024

Join us in congratulating John Sears on earning this world-class distinction for patent professionals.

IAM, a leader in intellectual property value creation, has selected JMIN Senior Partner John Sears to the Strategy 300 for 2024. Read more.

08/20/2024

In its recent decision in USA v. MSN Labs, the Federal Circuit clarified the scope of obviousness-type double patenting ( ) and attempted to resolve the confusion created by its earlier decision in In re Cellect.

The Federal Circuit’s recent decision in Allergan USA v. MSN Labs clarified the scope of obviousness-type double patenting and attempted to resolve the confusion created by its earlier decision in In re Cellect. Read more.

03/29/2024

Need to boost business innovation? Discover how patent pooling can propel your business forward and learn how to navigate its potential legal complexities.

Explore the power of patent pooling for businesses. Dive into its benefits, legal risks, and how to navigate patent pool agreements effectively.

01/09/2024

Have you ever wondered about the benefits of patenting your business method? JMIN's Bill Isaacs discusses how a patent can protect your innovation, give you a competitive edge, and even create new revenue streams. Read more.

How patentable business methods protect your business from infringement and provide a competitive edge. How patentable business methods protect your business from infringement and provide a competitive edge.

12/29/2023

We are thrilled to welcome Christopher Southgate to JMIN's esteemed Patents and IP Strategy practices!

With a wealth of experience and an unwavering commitment to excellence, Christopher brings a dynamic perspective to our team. His dedication to innovation and strategic thinking aligns perfectly with JMIN's mission to redefine excellence in the legal field.

Read more about Christopher here: https://bit.ly/47fNhyP

Christopher D. Southgate Joins JMIN's Patents and IP Strategy Practices

11/16/2023

Researchers have made significant strides in the generative design of new protein therapies. Brent Nix dissects this technology’s potential to reshape the landscape of therapeutic development. Learn more.

Discover recent strides made in the biotechnology field affecting Generative AI and Patent Law.